PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells

od Liu, Hao, Al-aidaroos, Abdul Qader Omer, Wang, Haihe, Guo, Ke, Li, Jie, Zhang, Hua Fei, Zeng, Qi
Izdano 2013

Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells

od Al-aidaroos, Abdul Qader Omer, Yuen, Hiu Fung, Guo, Ke, Zhang, Shu Dong, Chung, Tae-Hoon, Chng, Wee Joo, Zeng, Qi
Izdano 2013

Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells

od Al-aidaroos, Abdul Qader Omer, Yuen, Hiu Fung, Guo, Ke, Zhang, Shu Dong, Chung, Tae-Hoon, Chng, Wee Joo, Zeng, Qi
Izdano 2013

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse

od Thura, Min, Ye, Zu, Al-Aidaroos, Abdul Qader, Xiong, Qiancheng, Ong, Jun Yi, Gupta, Abhishek, Li, Jie, Guo, Ke, Ang, Koon Hwee, Zeng, Qi
Izdano u Commun Biol (2021)

PRL-3 activates mTORC1 in Cancer Progression

od Ye, Zu, Al-aidaroos, Abdul Qader Omer, Park, Jung Eun, Yuen, Hiu Fung, Zhang, Shu Dong, Gupta, Abhishek, Lin, Youbin, Shen, Han-Ming, Zeng, Qi
Izdano u Sci Rep (2015)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

od Park, Jung Eun, Yuen, Hiu Fung, Zhou, Jian Biao, Al-aidaroos, Abdul Qader O, Guo, Ke, Valk, Peter J, Zhang, Shu Dong, Chng, Wee Joo, Hong, Cheng William, Mills, Ken, Zeng, Qi
Izdano 2013

Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice

od Guo, Ke, Tang, Jing Ping, Jie, Li, Al-Aidaroos, Abdul Qader O., Hong, Cheng William, Tan, Cheng Peow Bobby, Park, Jung Eun, Varghese, Leyon, Feng, Zhiwei, Zhou, Jianbiao, Chng, Wee Joo, Zeng, Qi
Izdano 2012

A role of autophagy in PTP4A3-driven cancer progression

od Huang, Yu-Han, Al-aidaroos, Abdul Qader O, Yuen, Hiu-Fung, Zhang, Shu-Dong, Shen, Han-Ming, Rozycka, Ewelina, McCrudden, Cian M, Tergaonkar, Vinay, Gupta, Abhishek, Lin, You Bin, Thiery, Jean Paul, Murray, James T, Zeng, Qi
Izdano 2014

PRL3-zumab, a first-in-class humanized antibody for cancer therapy

od Thura, Min, Al-Aidaroos, Abdul Qader Omer, Yong, Wei Peng, Kono, Koji, Gupta, Abhishek, Lin, You Bin, Mimura, Kousaku, Thiery, Jean Paul, Goh, Boon Cher, Tan, Patrick, Soo, Ross, Hong, Cheng William, Wang, Lingzhi, Lin, Suling Joyce, Chen, Elya, Rha, Sun Young, Chung, Hyun Cheol, Li, Jie, Nandi, Sayantani, Yuen, Hiu Fung, Zhang, Shu-Dong, Guan, Yeoh Khay, So, Jimmy, Zeng, Qi
Izdano u JCI Insight (2016)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

od Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Izdano u Nat Commun (2019)